| Nombre | apoyo | Revisión | Disponibilidad | Fecha de emisión | Precio | ||
|---|---|---|---|---|---|---|---|
|
PDF |
Inglés |
Vigente |
9/11/2020 |
193,00 € |
|
||
Detalles
This guideline provides consensus guidelines for health care professionals, in vitro diagnostic and medical device manufacturers, and regulatory agencies regarding the use of continuous glucose monitoring (CGM) systems and data obtained from CGM systems. This guideline covers how CGM data should be assessed for accuracy, how CGM systems should be assessed for factors that can decrease accuracy, and how CGMs should be operated for optimal performance.
Información adicional
| Autor | Clinical and Laboratory Standards Institute (CLSI) |
|---|---|
| Publicado por | CLSI |
| Tipo de Documento | Norma |
| Tema | /subgroups/17905 |
| Edición | 2 |
| EAN ISBN | 9781684401017, 9781684401000 |
| Número de páginas | 82 |
| Reemplaza | CLSI POCT05-A |
| Palabra clave | CLSI POCT05 |
